IGF1 and Alzheimer disease: In this experimental model of AD, phycocyanin treatment significantly attenuated neuroinflammation and enhanced BDNF as well as insulin-like growth factor-1 (IGF-1) levels that increased regulation of insulin receptor substrate-1 (IRS-1).